New Oral Anticoagulants vs Vitamin K Antagonists: Benefits for Health-Related Quality of Life in Patients with Atrial Fibrillation

New oral anticoagulants (NOAC) have demonstrated their efficacy as an alternative to vitamin K antagonists (VKA) in the prophylaxis of cardioembolic events in patients with atrial fibrillation (AF). However, evidence on the benefits of NOAC in health-related quality of life (HRQoL) is lacking.We eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Alegret, Josep M., Viñolas, Xavier, Arias, Miguel A., Martínez-Rubio, Antoni, Rebollo, Pablo, Ràfols, Carles, Martínez-Sande, José L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025166/
https://www.ncbi.nlm.nih.gov/pubmed/24843316
http://dx.doi.org/10.7150/ijms.8916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025166/
https://www.ncbi.nlm.nih.gov/pubmed/24843316
http://dx.doi.org/10.7150/ijms.8916

Ejemplares similares